These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3320337)

  • 1. [Synthetic approach to pharmacologically active heterocycles].
    Yamazaki T; Takahata H
    Yakugaku Zasshi; 1987 Jul; 107(7):459-70. PubMed ID: 3320337
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antioxidant activity of bis and tris heterocycles.
    Mahaboob Basha N; Seenaiah D; Padmaja A; Padmavathi V; Bhargav DS; Vijaya T
    Arch Pharm (Weinheim); 2014 Jan; 347(1):54-67. PubMed ID: 24214732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antioxidant activity of a new class of mono- and bis-heterocycles.
    Mallikarjuna Reddy G; Ramachandra Reddy P; Padmavathi V; Padmaja A
    Arch Pharm (Weinheim); 2013 Feb; 346(2):154-62. PubMed ID: 23325517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antioxidant activity of a new class of bis and tris heterocycles.
    Padmavathi V; Venkatesh BC; Muralikrishna A; Padmaja A
    Arch Pharm (Weinheim); 2012 Sep; 345(9):745-52. PubMed ID: 22592954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and bioassay of a new class of heterocycles pyrrolyl oxadiazoles/thiadiazoles/triazoles.
    Padmavathi V; Nagendra Mohan AV; Thriveni P; Shazia A
    Eur J Med Chem; 2009 May; 44(5):2313-21. PubMed ID: 18547683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARgamma agonists.
    Blanc-Delmas E; Lebegue N; Wallez V; Leclerc V; Yous S; Carato P; Farce A; Bennejean C; Renard P; Caignard DH; Audinot-Bouchez V; Chomarat P; Boutin J; Hennuyer N; Louche K; Carmona MC; Staels B; Pénicaud L; Casteilla L; Lonchampt M; Dacquet C; Chavatte P; Berthelot P; Lesieur D
    Bioorg Med Chem; 2006 Nov; 14(22):7377-91. PubMed ID: 16887353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterocyclic core analogs of a direct thrombin inhibitor.
    Blizzard TA; Singh S; Patil B; Chidurala N; Komanduri V; Debnath S; Belyakov S; Crespo A; Struck A; Kurtz M; Wiltsie J; Shen X; Sonatore L; Arocho M; Lewis D; Ogletree M; Biftu T
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1111-5. PubMed ID: 24461292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
    Rachakonda V; Alla M; Kotipalli SS; Ummani R
    Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic approaches to some new sulfur-containing heterocycles of anticipated immunosuppressive activity.
    Girges MM; Hanna MA; Ayyad SN
    Boll Chim Farm; 1995 Apr; 134(4):204-8. PubMed ID: 7605605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combinatorial scaffold approach toward kinase-directed heterocycle libraries.
    Ding S; Gray NS; Wu X; Ding Q; Schultz PG
    J Am Chem Soc; 2002 Feb; 124(8):1594-6. PubMed ID: 11853431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Pharmacological Heterocyclic Derivatives Based Surfactants.
    El-Sayed R; Fadda AA
    J Oleo Sci; 2016; 65(11):929-940. PubMed ID: 27803492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, screening and docking of small heterocycles as glycogen phosphorylase inhibitors.
    Schweiker SS; Loughlin WA; Lohning AS; Petersson MJ; Jenkins ID
    Eur J Med Chem; 2014 Sep; 84():584-94. PubMed ID: 25062009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of some new spiro indoline-based heterocycles as potentially active antimicrobial agents.
    Abdel-Rahman AH; Keshk EM; Hanna MA; el-Bady ShM
    Bioorg Med Chem; 2004 May; 12(9):2483-8. PubMed ID: 15080944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-heterocyclic derived M1 positive allosteric modulators.
    Kuduk SD; Di Marco CN; Cofre V; Pitts DR; Ray WJ; Ma L; Wittmann M; Veng L; Seager MA; Koeplinger K; Thompson CD; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1334-7. PubMed ID: 20097564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Current Status of O-Heterocycles: A Synthetic and Medicinal Overview.
    Singh PK; Silakari O
    ChemMedChem; 2018 Jun; 13(11):1071-1087. PubMed ID: 29603634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors.
    Wilson KJ; Illig CR; Chen J; Wall MJ; Ballentine SK; DesJarlais RL; Chen Y; Schubert C; Donatelli R; Petrounia I; Crysler CS; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Meegalla SK
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3925-9. PubMed ID: 20570147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterocyclic diversity: the road to biological activity.
    de Stevens G
    Prog Drug Res; 1995; 44():9-48. PubMed ID: 7644669
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-peptidic small molecule inhibitors of XIAP.
    Park CM; Sun C; Olejniczak ET; Wilson AE; Meadows RP; Betz SF; Elmore SW; Fesik SW
    Bioorg Med Chem Lett; 2005 Feb; 15(3):771-5. PubMed ID: 15664855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterocyclic electrophiles as new MurA inhibitors.
    Keeley A; Ábrányi-Balogh P; Hrast M; Imre T; Ilaš J; Gobec S; Keserű GM
    Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800184. PubMed ID: 30461051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of uriedo and thiouriedo derivatives of peptide conjugated heterocycles - A new class of promising antimicrobials.
    Suhas R; Chandrashekar S; Gowda DC
    Eur J Med Chem; 2012 Feb; 48():179-91. PubMed ID: 22209564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.